Crescent Capital Consulting’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	$5.82M	Buy	38,102 +2,895	+8%	+$442K	0.96%	29
2021 Q3	$5.69M	Buy	35,207 +8,665	+33%	+$1.4M	1.04%	23
2021 Q2	$4.34M	Buy	26,542 +3,325	+14%	+$543K	0.81%	33
2021 Q1	$3.49M	Buy	23,217 +3,349	+17%	+$503K	0.77%	38
2020 Q4	$3.01M	Buy	+19,868	New	+$3.01M	0.78%	32